ICAM1 and renal cell carcinoma: Our study shows that SIGIRR downregulation in RCC cells unleashes an inflammatory signaling intrinsic to renal cancer cells that leads to NFKBIZ activation, IL6 induction, MMP1 upregulation, and notably higher levels of PD-L1 and ICAM1 expression.